Skip to main content
GCTK
NASDAQ Industrial Applications And Services

Nasdaq to Delist Glucotrack; Trading Suspended October 30

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.345
Mkt Cap
$1.646M
52W Low
$0.746
52W High
$207.12
52W Position info
80% above low
Off High info
99% below high
Rel. Volume info
2.2× avg
Market data snapshot near publication time

GCTK sits 80% above its 52-week low of $0.746 on elevated volume (2.2× avg).

Summary

Nasdaq will delist Glucotrack after the stock failed to hold $1.00, with trading suspended at the open on October 30, 2026. The company intends to move its shares to the OTCID market.


Key Events · Legal and Risk Events · GCTK

  • Nasdaq Panel Orders Delisting

    On October 28, 2026 the Nasdaq Hearings Panel determined to delist Glucotrack because its closing bid price was $0.87 on October 14, 2026, failing the terms of its bid-price exception.

  • Trading Suspended October 30

    Trading in the common stock on Nasdaq will be suspended at the open of trading on October 30, 2026, and Nasdaq is expected to file a Form 25 to delist and deregister the shares under Section 12(b).

  • OTCID Quotation Planned

    The company expects its shares to be quoted by OTC Markets and intends to apply for trading on the OTCID Market, a lower-tier venue with thinner liquidity than Nasdaq.

  • Prior Bid-Price Exception Failed

    The exception required a closing bid price of at least $1.00 for each trading day through November 9, 2026; the $0.87 close on October 14, 2026 broke that condition before the deadline.


Analysis · GCTK · Industrial Applications And Services

The Nasdaq Hearings Panel has rejected Glucotrack's bid-price exception after the stock closed at $0.87 on October 14, 2026, so trading halts at the open on October 30, 2026 and Nasdaq will file a Form 25 to delist and deregister the shares. The company plans to move to the OTCID tier of OTC Markets, a far thinner venue with wider spreads and limited institutional participation. This lands on top of a going-concern warning and a string of discounted convertible financings, so the practical risk is that already-stressed liquidity gets harder to manage when the stock loses its Nasdaq listing.

How filings like this one have moved

In the 30 days to Oct 29, 2026, 47.6% of the 231 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, GCTK was trading at $1.35 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6M. The 52-week trading range was $0.75 to $207.12. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

GCTK - Latest Insights

GCTK
Oct 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
GCTK
Oct 22, 2026, 5:29 PM EDT
Filing Type: 8-K
Importance Score:
8
GCTK
Oct 22, 2026, 9:18 AM EDT
Source: Seeking Alpha
Importance Score:
7
GCTK
Oct 19, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
GCTK
Oct 14, 2026, 10:02 AM EDT
Filing Type: PRE 14A
Importance Score:
9